| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $48.2M | +25.2% |
| SG&A Expense | $13.0M | -5.4% |
| Operating Income | -$61.2M | -17.2% |
| Pre-tax Income | -$61.6M | -19.1% |
| Income Tax | $0 | — |
| Net Income | -$61.6M | -19.1% |
| EPS (Basic) | -$2.43 | -18.5% |
| EPS (Diluted) | -$2.43 | -18.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $32.8M | -47.6% |
| Short-term Investments | $27.4M | -27.1% |
| Current Assets | $63.9M | -42.0% |
| Total Assets | $73.2M | -40.1% |
| Current Liabilities | $11.1M | +144.4% |
| Total Liabilities | $11.4M | +129.1% |
| Stockholders' Equity | $61.8M | -47.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$42.9M | +17.9% |
| Capital Expenditures | $196K | -12.1% |
| Investing Cash Flow | $12.4M | +125.8% |
| Financing Cash Flow | $507K | — |
| Free Cash Flow | -$43.1M | +17.9% |